A. Reeves

发表

High-Throughput Screening of Type III Secretion Determinants Reveals a Major Chaperone-Independent Pathway

C. Lesser, N. Ernst, A. Reeves, 2018, mBio.

Disparities in Capreomycin Resistance Levels Associated with the rrs A1401G Mutation in Clinical Isolates of Mycobacterium tuberculosis

J. Posey, A. Reeves, M. Willby, 2014, Antimicrobial Agents and Chemotherapy.

Engineering Escherichia coli into a Protein Delivery System for Mammalian Cells

A. Wagers, Juan Du, K. Tan, 2015, ACS synthetic biology.

QseC inhibition as an antivirulence approach for colitis-associated bacteria

C. Huttenhower, W. Garrett, M. Rooks, 2016, Proceedings of the National Academy of Sciences.

The type III secretion system apparatus determines the intracellular niche of bacterial pathogens

L. Knodler, C. Lesser, A. Reeves, 2016, Proceedings of the National Academy of Sciences.

Engineered E. coli for the targeted deposition of therapeutic payloads to sites of disease

H. Ploegh, W. Garrett, J. Glickman, 2022 .

SUMMER DIET AND STATUS OF RIVER OTTERS ON REDWOOD CREEK

A. Reeves, 1988 .

Monocarbonyl analogs of curcumin inhibit growth of antibiotic sensitive and resistant strains of Mycobacterium tuberculosis.

J. Snyder, D. Kalman, D. Liotta, 2015, European journal of medicinal chemistry.

Aminoglycoside Cross-Resistance in Mycobacterium tuberculosis Due to Mutations in the 5′ Untranslated Region of whiB7

R. Sultana, J. Posey, M. Murray, 2013, Antimicrobial Agents and Chemotherapy.

Engineered Escherichia coli for the in situ secretion of therapeutic nanobodies in the gut.

H. Ploegh, W. Garrett, J. Glickman, 2023, Cell host & microbe.

Synthetic bottom-up approach reveals the complex interplay of Shigella effectors in regulation of epithelial cell death

C. Lesser, A. Reeves, Juan Du, 2018, Proceedings of the National Academy of Sciences.